COVID-19 infection in NMO/SD patients: a French survey

J Neurol. 2021 Apr;268(4):1188-1190. doi: 10.1007/s00415-020-10112-1. Epub 2020 Sep 12.

Authors

Sinéad Zeidan¹, Elisabeth Maillart¹, Céline Louapre^{1

2}, Thomas Roux¹, Catherine Lubetzki^{1

2}, Caroline Papeix³

Affiliations

¹ Department of Neurology, Pitié Salpêtrière Hospital, APHP, Sorbonne University, 75013, Paris, France.
² Institut du Cerveau et de la Moelle épinière, ICM, CIC Neuroscience, Paris, France.
³ Department of Neurology, Pitié Salpêtrière Hospital, APHP, Sorbonne University, 75013, Paris, France. caroline.papeix@aphp.fr.

No abstract available

Keywords: AQP4; COVID-19; Immunosuppressants; NMOSD.

Publication types

Letter

MeSH terms

Adult
COVID-19 / complications*
COVID-19 / epidemiology*
Case-Control Studies
Female
France
Humans
Male
Middle Aged
Neuromyelitis Optica / complications*
Neuromyelitis Optica / virology
Prevalence
Retrospective Studies
SARS-CoV-2
Surveys and Questionnaires